- Home
- LRHC vs QNRX Comparison
LRHC vs QNRX Comparison
Compare LRHC & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- QNRX
- Stock Information
- Founded
- LRHC 2004
- QNRX 2018
- Country
- LRHC United States
- QNRX United States
- Employees
- LRHC N/A
- QNRX N/A
- Industry
- LRHC
- QNRX Medical/Dental Instruments
- Sector
- LRHC
- QNRX Health Care
- Exchange
- LRHC Nasdaq
- QNRX Nasdaq
- Market Cap
- LRHC 5.4M
- QNRX 4.3M
- IPO Year
- LRHC 2023
- QNRX N/A
- Fundamental
- Price
- LRHC $5.90
- QNRX $7.62
- Analyst Decision
- LRHC
- QNRX
- Analyst Count
- LRHC 0
- QNRX 0
- Target Price
- LRHC N/A
- QNRX N/A
- AVG Volume (30 Days)
- LRHC 36.3K
- QNRX 2.8K
- Earning Date
- LRHC 08-18-2025
- QNRX 08-07-2025
- Dividend Yield
- LRHC N/A
- QNRX N/A
- EPS Growth
- LRHC N/A
- QNRX N/A
- EPS
- LRHC N/A
- QNRX N/A
- Revenue
- LRHC $78,037,079.00
- QNRX N/A
- Revenue This Year
- LRHC N/A
- QNRX N/A
- Revenue Next Year
- LRHC N/A
- QNRX N/A
- P/E Ratio
- LRHC N/A
- QNRX N/A
- Revenue Growth
- LRHC 54.92
- QNRX N/A
- 52 Week Low
- LRHC $4.33
- QNRX $5.01
- 52 Week High
- LRHC $142.40
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- LRHC 48.10
- QNRX 52.49
- Support Level
- LRHC $5.49
- QNRX $7.38
- Resistance Level
- LRHC $6.12
- QNRX $7.74
- Average True Range (ATR)
- LRHC 0.45
- QNRX 0.19
- MACD
- LRHC 0.16
- QNRX 0.10
- Stochastic Oscillator
- LRHC 66.45
- QNRX 83.65
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.